EP3446577B1 - Remplissage de tabac pour article à fumer à chauffage de type sans combustion - Google Patents
Remplissage de tabac pour article à fumer à chauffage de type sans combustion Download PDFInfo
- Publication number
- EP3446577B1 EP3446577B1 EP16903167.1A EP16903167A EP3446577B1 EP 3446577 B1 EP3446577 B1 EP 3446577B1 EP 16903167 A EP16903167 A EP 16903167A EP 3446577 B1 EP3446577 B1 EP 3446577B1
- Authority
- EP
- European Patent Office
- Prior art keywords
- acid
- tobacco
- mass
- smoke flavor
- smoking article
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 235000002637 Nicotiana tabacum Nutrition 0.000 title claims description 78
- 230000000391 smoking effect Effects 0.000 title claims description 48
- 238000010438 heat treatment Methods 0.000 title description 8
- 238000011049 filling Methods 0.000 title description 2
- 244000061176 Nicotiana tabacum Species 0.000 title 1
- 239000002253 acid Substances 0.000 claims description 93
- 241000208125 Nicotiana Species 0.000 claims description 77
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 claims description 63
- 239000000945 filler Substances 0.000 claims description 46
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims description 31
- 238000002485 combustion reaction Methods 0.000 claims description 31
- 239000000443 aerosol Substances 0.000 claims description 28
- 239000007788 liquid Substances 0.000 claims description 28
- 238000010494 dissociation reaction Methods 0.000 claims description 27
- 230000005593 dissociations Effects 0.000 claims description 27
- 238000009835 boiling Methods 0.000 claims description 26
- ISYWECDDZWTKFF-UHFFFAOYSA-N nonadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCCC(O)=O ISYWECDDZWTKFF-UHFFFAOYSA-N 0.000 claims description 22
- CKDDRHZIAZRDBW-UHFFFAOYSA-N henicosanoic acid Chemical compound CCCCCCCCCCCCCCCCCCCCC(O)=O CKDDRHZIAZRDBW-UHFFFAOYSA-N 0.000 claims description 12
- UTOPWMOLSKOLTQ-UHFFFAOYSA-N octacosanoic acid Chemical compound CCCCCCCCCCCCCCCCCCCCCCCCCCCC(O)=O UTOPWMOLSKOLTQ-UHFFFAOYSA-N 0.000 claims description 12
- CIWBSHSKHKDKBQ-DUZGATOHSA-N D-isoascorbic acid Chemical compound OC[C@@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-DUZGATOHSA-N 0.000 claims description 11
- 235000010350 erythorbic acid Nutrition 0.000 claims description 11
- 229940026239 isoascorbic acid Drugs 0.000 claims description 11
- 235000010323 ascorbic acid Nutrition 0.000 claims description 10
- 239000011668 ascorbic acid Substances 0.000 claims description 10
- 229960005070 ascorbic acid Drugs 0.000 claims description 10
- 235000021353 Lignoceric acid Nutrition 0.000 claims description 9
- CQXMAMUUWHYSIY-UHFFFAOYSA-N Lignoceric acid Natural products CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCCC1=CC=C(O)C=C1 CQXMAMUUWHYSIY-UHFFFAOYSA-N 0.000 claims description 9
- FARYTWBWLZAXNK-WAYWQWQTSA-N ethyl (z)-3-(methylamino)but-2-enoate Chemical compound CCOC(=O)\C=C(\C)NC FARYTWBWLZAXNK-WAYWQWQTSA-N 0.000 claims description 9
- 239000000796 flavoring agent Substances 0.000 description 64
- 239000000779 smoke Substances 0.000 description 64
- 235000019634 flavors Nutrition 0.000 description 62
- 230000005764 inhibitory process Effects 0.000 description 31
- 230000000052 comparative effect Effects 0.000 description 28
- 150000007513 acids Chemical class 0.000 description 18
- 235000013772 propylene glycol Nutrition 0.000 description 18
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 17
- 230000000694 effects Effects 0.000 description 11
- 239000000126 substance Substances 0.000 description 11
- 230000001629 suppression Effects 0.000 description 11
- SNICXCGAKADSCV-JTQLQIEISA-N (-)-Nicotine Chemical compound CN1CCC[C@H]1C1=CC=CN=C1 SNICXCGAKADSCV-JTQLQIEISA-N 0.000 description 6
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 6
- 238000011156 evaluation Methods 0.000 description 6
- 235000011187 glycerol Nutrition 0.000 description 6
- 229960002715 nicotine Drugs 0.000 description 6
- SNICXCGAKADSCV-UHFFFAOYSA-N nicotine Natural products CN1CCCC1C1=CC=CN=C1 SNICXCGAKADSCV-UHFFFAOYSA-N 0.000 description 6
- 238000012360 testing method Methods 0.000 description 6
- DOOTYTYQINUNNV-UHFFFAOYSA-N Triethyl citrate Chemical compound CCOC(=O)CC(O)(C(=O)OCC)CC(=O)OCC DOOTYTYQINUNNV-UHFFFAOYSA-N 0.000 description 4
- 239000003906 humectant Substances 0.000 description 4
- 238000000034 method Methods 0.000 description 4
- 150000003839 salts Chemical class 0.000 description 4
- 239000001069 triethyl citrate Substances 0.000 description 4
- VMYFZRTXGLUXMZ-UHFFFAOYSA-N triethyl citrate Natural products CCOC(=O)C(O)(C(=O)OCC)C(=O)OCC VMYFZRTXGLUXMZ-UHFFFAOYSA-N 0.000 description 4
- 235000013769 triethyl citrate Nutrition 0.000 description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- 239000004348 Glyceryl diacetate Substances 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 3
- 230000015572 biosynthetic process Effects 0.000 description 3
- 235000019504 cigarettes Nutrition 0.000 description 3
- 235000019443 glyceryl diacetate Nutrition 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 239000002904 solvent Substances 0.000 description 3
- JOOXCMJARBKPKM-UHFFFAOYSA-N 4-oxopentanoic acid Chemical compound CC(=O)CCC(O)=O JOOXCMJARBKPKM-UHFFFAOYSA-N 0.000 description 2
- VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 description 2
- HPEUJPJOZXNMSJ-UHFFFAOYSA-N Methyl stearate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC HPEUJPJOZXNMSJ-UHFFFAOYSA-N 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- LCTONWCANYUPML-UHFFFAOYSA-N Pyruvic acid Chemical compound CC(=O)C(O)=O LCTONWCANYUPML-UHFFFAOYSA-N 0.000 description 2
- 125000001931 aliphatic group Chemical group 0.000 description 2
- 239000003963 antioxidant agent Substances 0.000 description 2
- 235000006708 antioxidants Nutrition 0.000 description 2
- 239000011324 bead Substances 0.000 description 2
- 230000007423 decrease Effects 0.000 description 2
- ZDJFDFNNEAPGOP-UHFFFAOYSA-N dimethyl tetradecanedioate Chemical compound COC(=O)CCCCCCCCCCCCC(=O)OC ZDJFDFNNEAPGOP-UHFFFAOYSA-N 0.000 description 2
- POULHZVOKOAJMA-UHFFFAOYSA-N dodecanoic acid Chemical compound CCCCCCCCCCCC(O)=O POULHZVOKOAJMA-UHFFFAOYSA-N 0.000 description 2
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 210000000214 mouth Anatomy 0.000 description 2
- 230000001953 sensory effect Effects 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- KDYFGRWQOYBRFD-UHFFFAOYSA-N succinic acid Chemical compound OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 2
- 235000019505 tobacco product Nutrition 0.000 description 2
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 2
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
- WBYWAXJHAXSJNI-VOTSOKGWSA-M .beta-Phenylacrylic acid Natural products [O-]C(=O)\C=C\C1=CC=CC=C1 WBYWAXJHAXSJNI-VOTSOKGWSA-M 0.000 description 1
- GYSCBCSGKXNZRH-UHFFFAOYSA-N 1-benzothiophene-2-carboxamide Chemical compound C1=CC=C2SC(C(=O)N)=CC2=C1 GYSCBCSGKXNZRH-UHFFFAOYSA-N 0.000 description 1
- TWJNQYPJQDRXPH-UHFFFAOYSA-N 2-cyanobenzohydrazide Chemical compound NNC(=O)C1=CC=CC=C1C#N TWJNQYPJQDRXPH-UHFFFAOYSA-N 0.000 description 1
- SQERDRRMCKKWIL-UHFFFAOYSA-N 2-hydroperoxy-2-oxoacetic acid Chemical compound OOC(=O)C(O)=O SQERDRRMCKKWIL-UHFFFAOYSA-N 0.000 description 1
- 239000005711 Benzoic acid Substances 0.000 description 1
- WBYWAXJHAXSJNI-SREVYHEPSA-N Cinnamic acid Chemical compound OC(=O)\C=C/C1=CC=CC=C1 WBYWAXJHAXSJNI-SREVYHEPSA-N 0.000 description 1
- GHVNFZFCNZKVNT-UHFFFAOYSA-N Decanoic acid Natural products CCCCCCCCCC(O)=O GHVNFZFCNZKVNT-UHFFFAOYSA-N 0.000 description 1
- 241000282414 Homo sapiens Species 0.000 description 1
- 239000005639 Lauric acid Substances 0.000 description 1
- 235000021360 Myristic acid Nutrition 0.000 description 1
- TUNFSRHWOTWDNC-UHFFFAOYSA-N Myristic acid Natural products CCCCCCCCCCCCCC(O)=O TUNFSRHWOTWDNC-UHFFFAOYSA-N 0.000 description 1
- 235000021314 Palmitic acid Nutrition 0.000 description 1
- OFOBLEOULBTSOW-UHFFFAOYSA-N Propanedioic acid Natural products OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- DTOSIQBPPRVQHS-PDBXOOCHSA-N alpha-linolenic acid Chemical compound CC\C=C/C\C=C/C\C=C/CCCCCCCC(O)=O DTOSIQBPPRVQHS-PDBXOOCHSA-N 0.000 description 1
- 235000020661 alpha-linolenic acid Nutrition 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 235000010233 benzoic acid Nutrition 0.000 description 1
- 150000001732 carboxylic acid derivatives Chemical class 0.000 description 1
- 150000001735 carboxylic acids Chemical class 0.000 description 1
- 239000003638 chemical reducing agent Substances 0.000 description 1
- 229930016911 cinnamic acid Natural products 0.000 description 1
- 235000013985 cinnamic acid Nutrition 0.000 description 1
- 238000009833 condensation Methods 0.000 description 1
- 230000005494 condensation Effects 0.000 description 1
- 230000002596 correlated effect Effects 0.000 description 1
- 238000012258 culturing Methods 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- IZMOTZDBVPMOFE-UHFFFAOYSA-N dimethyl dodecanedioate Chemical compound COC(=O)CCCCCCCCCCC(=O)OC IZMOTZDBVPMOFE-UHFFFAOYSA-N 0.000 description 1
- CAMHHLOGFDZBBG-UHFFFAOYSA-N epoxidized methyl oleate Natural products CCCCCCCCC1OC1CCCCCCCC(=O)OC CAMHHLOGFDZBBG-UHFFFAOYSA-N 0.000 description 1
- BEFDCLMNVWHSGT-UHFFFAOYSA-N ethenylcyclopentane Chemical compound C=CC1CCCC1 BEFDCLMNVWHSGT-UHFFFAOYSA-N 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 239000001530 fumaric acid Substances 0.000 description 1
- 238000000769 gas chromatography-flame ionisation detection Methods 0.000 description 1
- 238000000227 grinding Methods 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 150000004715 keto acids Chemical class 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 229940040102 levulinic acid Drugs 0.000 description 1
- 229960004488 linolenic acid Drugs 0.000 description 1
- KQQKGWQCNNTQJW-UHFFFAOYSA-N linolenic acid Natural products CC=CCCC=CCC=CCCCCCCCC(O)=O KQQKGWQCNNTQJW-UHFFFAOYSA-N 0.000 description 1
- VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 description 1
- 239000011976 maleic acid Substances 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 229940126601 medicinal product Drugs 0.000 description 1
- WBYWAXJHAXSJNI-UHFFFAOYSA-N methyl p-hydroxycinnamate Natural products OC(=O)C=CC1=CC=CC=C1 WBYWAXJHAXSJNI-UHFFFAOYSA-N 0.000 description 1
- 150000007522 mineralic acids Chemical class 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- WQEPLUUGTLDZJY-UHFFFAOYSA-N n-Pentadecanoic acid Natural products CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- 230000001590 oxidative effect Effects 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 230000035515 penetration Effects 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 229940107700 pyruvic acid Drugs 0.000 description 1
- 230000035807 sensation Effects 0.000 description 1
- 235000019615 sensations Nutrition 0.000 description 1
- 239000004334 sorbic acid Substances 0.000 description 1
- 235000010199 sorbic acid Nutrition 0.000 description 1
- 229940075582 sorbic acid Drugs 0.000 description 1
- 230000002269 spontaneous effect Effects 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- 239000001384 succinic acid Substances 0.000 description 1
- 150000005846 sugar alcohols Polymers 0.000 description 1
- 239000011975 tartaric acid Substances 0.000 description 1
- 235000002906 tartaric acid Nutrition 0.000 description 1
- UWHCKJMYHZGTIT-UHFFFAOYSA-N tetraethylene glycol Chemical compound OCCOCCOCCOCCO UWHCKJMYHZGTIT-UHFFFAOYSA-N 0.000 description 1
- ZIBGPFATKBEMQZ-UHFFFAOYSA-N triethylene glycol Chemical compound OCCOCCOCCO ZIBGPFATKBEMQZ-UHFFFAOYSA-N 0.000 description 1
- 238000009834 vaporization Methods 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
- A24B—MANUFACTURE OR PREPARATION OF TOBACCO FOR SMOKING OR CHEWING; TOBACCO; SNUFF
- A24B15/00—Chemical features or treatment of tobacco; Tobacco substitutes, e.g. in liquid form
- A24B15/10—Chemical features of tobacco products or tobacco substitutes
- A24B15/16—Chemical features of tobacco products or tobacco substitutes of tobacco substitutes
- A24B15/167—Chemical features of tobacco products or tobacco substitutes of tobacco substitutes in liquid or vaporisable form, e.g. liquid compositions for electronic cigarettes
-
- A—HUMAN NECESSITIES
- A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
- A24B—MANUFACTURE OR PREPARATION OF TOBACCO FOR SMOKING OR CHEWING; TOBACCO; SNUFF
- A24B15/00—Chemical features or treatment of tobacco; Tobacco substitutes, e.g. in liquid form
- A24B15/18—Treatment of tobacco products or tobacco substitutes
- A24B15/28—Treatment of tobacco products or tobacco substitutes by chemical substances
- A24B15/30—Treatment of tobacco products or tobacco substitutes by chemical substances by organic substances
- A24B15/32—Treatment of tobacco products or tobacco substitutes by chemical substances by organic substances by acyclic compounds
-
- A—HUMAN NECESSITIES
- A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
- A24B—MANUFACTURE OR PREPARATION OF TOBACCO FOR SMOKING OR CHEWING; TOBACCO; SNUFF
- A24B15/00—Chemical features or treatment of tobacco; Tobacco substitutes, e.g. in liquid form
- A24B15/10—Chemical features of tobacco products or tobacco substitutes
- A24B15/12—Chemical features of tobacco products or tobacco substitutes of reconstituted tobacco
-
- A—HUMAN NECESSITIES
- A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
- A24B—MANUFACTURE OR PREPARATION OF TOBACCO FOR SMOKING OR CHEWING; TOBACCO; SNUFF
- A24B15/00—Chemical features or treatment of tobacco; Tobacco substitutes, e.g. in liquid form
- A24B15/10—Chemical features of tobacco products or tobacco substitutes
- A24B15/12—Chemical features of tobacco products or tobacco substitutes of reconstituted tobacco
- A24B15/14—Chemical features of tobacco products or tobacco substitutes of reconstituted tobacco made of tobacco and a binding agent not derived from tobacco
-
- A—HUMAN NECESSITIES
- A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
- A24B—MANUFACTURE OR PREPARATION OF TOBACCO FOR SMOKING OR CHEWING; TOBACCO; SNUFF
- A24B15/00—Chemical features or treatment of tobacco; Tobacco substitutes, e.g. in liquid form
- A24B15/18—Treatment of tobacco products or tobacco substitutes
- A24B15/28—Treatment of tobacco products or tobacco substitutes by chemical substances
-
- A—HUMAN NECESSITIES
- A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
- A24B—MANUFACTURE OR PREPARATION OF TOBACCO FOR SMOKING OR CHEWING; TOBACCO; SNUFF
- A24B15/00—Chemical features or treatment of tobacco; Tobacco substitutes, e.g. in liquid form
- A24B15/18—Treatment of tobacco products or tobacco substitutes
- A24B15/28—Treatment of tobacco products or tobacco substitutes by chemical substances
- A24B15/30—Treatment of tobacco products or tobacco substitutes by chemical substances by organic substances
-
- A—HUMAN NECESSITIES
- A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
- A24B—MANUFACTURE OR PREPARATION OF TOBACCO FOR SMOKING OR CHEWING; TOBACCO; SNUFF
- A24B15/00—Chemical features or treatment of tobacco; Tobacco substitutes, e.g. in liquid form
- A24B15/18—Treatment of tobacco products or tobacco substitutes
- A24B15/28—Treatment of tobacco products or tobacco substitutes by chemical substances
- A24B15/30—Treatment of tobacco products or tobacco substitutes by chemical substances by organic substances
- A24B15/36—Treatment of tobacco products or tobacco substitutes by chemical substances by organic substances containing a heterocyclic ring
- A24B15/40—Treatment of tobacco products or tobacco substitutes by chemical substances by organic substances containing a heterocyclic ring having only oxygen or sulfur as hetero atoms
- A24B15/403—Treatment of tobacco products or tobacco substitutes by chemical substances by organic substances containing a heterocyclic ring having only oxygen or sulfur as hetero atoms having only oxygen as hetero atoms
- A24B15/406—Treatment of tobacco products or tobacco substitutes by chemical substances by organic substances containing a heterocyclic ring having only oxygen or sulfur as hetero atoms having only oxygen as hetero atoms in a five-membered ring
-
- A—HUMAN NECESSITIES
- A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
- A24F—SMOKERS' REQUISITES; MATCH BOXES; SIMULATED SMOKING DEVICES
- A24F42/00—Simulated smoking devices other than electrically operated; Component parts thereof; Manufacture or testing thereof
- A24F42/10—Devices with chemical heating means
-
- A—HUMAN NECESSITIES
- A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
- A24F—SMOKERS' REQUISITES; MATCH BOXES; SIMULATED SMOKING DEVICES
- A24F47/00—Smokers' requisites not otherwise provided for
-
- A—HUMAN NECESSITIES
- A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
- A24F—SMOKERS' REQUISITES; MATCH BOXES; SIMULATED SMOKING DEVICES
- A24F40/00—Electrically operated smoking devices; Component parts thereof; Manufacture thereof; Maintenance or testing thereof; Charging means specially adapted therefor
- A24F40/10—Devices using liquid inhalable precursors
Definitions
- the present invention relates to the use of a tobacco filler for a non-combustion smoking article and a non-combustion smoking article which is filled with the tobacco filler.
- non-combustion smoking articles that replace cigarettes and allow experience of a smoke flavor without combusting tobacco have been developed, and one in which a smoke flavor component and a component capable of generating aerosol fill a pod-shaped container for use or one having a heat source at a tip thereof is typically known.
- US 2011/232657 A1 is concerned with encapsulated tobacco beads which are used in snus type products and/or smoking articles likes cigarettes.
- the tobacco beads may contain 0.001 to 5 wt.% of a humectant, and they may contain antioxidants and/or preservatives, which may inter alia be selected from ascorbic acid.
- US 5,713,376 provides a tobacco product comprising nicotine in an amount below about 0.01 milligram per gram.
- the tobacco product contains a small amount of propylene glycol as a flavourant and a mixture of ascorbic acid, citric acid and maleic acid for oxidizing nicotine.
- EP 1 723 858 A1 provides a smoking composition for a hookah.
- the tobacco material may contain propylene glycol as a humectant and ascorbic acid as a flavourant.
- GB 2 203 022 A inter alia describes a process for culturing tobacco cells having an enhanced level of nicotine.
- the smoking material may contain an antioxidant, which may be ascorbic acid, and it may contain a humectant, which may among others be propylene glycol.
- the material may contain a humectant like glycerin or propylene glycol.
- Ascorbic acid or isoascorbic acid may be used as a reducing agent for treating the tobacco.
- the amount of evaporation of smoke flavor components may be insufficient compared to that from cigarettes or a user may feel so-called "smoke flavor inhibition".
- An object of the present invention is to provide a tobacco filler which is used for a non-combustion smoking article that can suppress a reduction in an amount of evaporated smoke flavor components and suppress "smoke flavor inhibition" in a non-combustion smoking article, particularly a smoking article in which a filler containing shredded tobacco is heated.
- the inventors of the present invention carried out an extensive study in order to solve the problem and, as a result, found that by adding an acid fulfilling specific conditions to a tobacco filler, a reduction in the amount of evaporated smoke flavor components may be suppressed and "smoke flavor inhibition" may be suppressed, thereby completing the present invention.
- the present invention is defined in the appended claims. It relates to:
- a reduction in the amount of evaporated smoke flavor components may be suppressed and "smoke flavor inhibition" may be suppressed in a non-combustion smoking article in which a filler containing shredded tobacco is heated.
- the tobacco filler used for a non-combustion smoking article contains shredded tobacco, and liquid that generates aerosol, and is characterized in that the tobacco filler contains an acid that has a first acid dissociation constant of 4.0 to 6.0 inclusive and a boiling point of 366°C to 600°C inclusive.
- the inventors of the present invention have revealed various issues on non-combustion smoking articles, particularly smoking articles in which a filler containing shredded tobacco is heated.
- the amount of evaporated smoke flavor components may be reduced. This may be caused by penetration of added acid into shredded tobacco together with liquid that generates aerosol and formation of salts with smoke flavor components in shredded tobacco.
- salts may be dissociated by heating or a reduction in the amount of evaporated smoke flavor components may be suppressed due to high temperature, while the influences may be significant in non-combustion smoking articles which are heated to low temperature.
- smoke flavor inhibition such as receiving a stimulus that is different from tobacco or generating physiological spontaneous actions such as “choking”. This may be caused by components that inhibit smoke flavor in a filler, and volatilization of the components together with solvents such as propylene glycol may cause "smoke flavor inhibition”.
- the inventors of the present invention revealed that formation of salts from acids and smoke flavor components in shredded tobacco is correlated with the first acid dissociation constant (pKa 1 ) representing the strength of acid and formation of salts may be suppressed by selecting an acid having a first acid dissociation constant within a specific range, and less chemical odor (chemical smell) may be sensed by selecting an acid having a boiling point at or above a certain temperature.
- pKa 1 the first acid dissociation constant representing the strength of acid and formation of salts
- the inventors of the present invention found that by adding an "acid that has a first acid dissociation constant of 4.0 to 6.0 inclusive and a boiling point of 366°C to 600°C inclusive" to a tobacco filler, a reduction in the amount of evaporated smoke flavor components may be suppressed and "smoke flavor inhibition" may be suppressed.
- the "first acid dissociation constant” means an acid dissociation constant in water at normal temperature (25°C).
- boiling point means a boiling point at pressure of 760 mmHg.
- non-combustion smoking article "shredded tobacco”, “liquid that generates aerosol”, “acid that has a first acid dissociation constant of 4.0 to 6.0 inclusive and a boiling point of 366°C to 600°C inclusive” and the like are hereinafter specifically described.
- the tobacco filler used according to the present invention for a non-combustion smoking article contains shredded tobacco, and liquid that generates aerosol.
- the non-combustion smoking article which is filled with the tobacco filler is not particularly limited, for example, as to the specific structure thereof, and may appropriately be any well-known non-combustion smoking article.
- the non-combustion smoking article is hereinafter described by way of specific examples.
- non-combustion smoking article examples include the one that has the structure as a non-combustion smoking article 10 illustrated in Fig. 1.
- Fig. 1 is a section view of the cylindrical non-combustion smoking article 10 along the longitudinal direction.
- the non-combustion smoking article 10 has the structure having a battery 101, a pod 103 that accommodates a filler 102 and a heater 104 and a mouthpiece 105. By filling the pod 103 with the tobacco filler and heating the same, aerosol is generated.
- the heating temperature of the tobacco filler in the non-combustion smoking article is generally 22°C or higher, preferably 100°C or higher and more preferably 150°C or higher, and generally 350°C or lower, preferably 300°C or lower and more preferably 250°C or lower.
- the non-combustion smoking article having a heating temperature of a tobacco filler within the above range tends to have an issue of "smoke flavor inhibition", and thus characteristics of the tobacco filler may be more efficiently exploited.
- Examples of the type of the shredded tobacco include flue-cured tobacco, Burley tobacco, Japanese domestic tobacco, and regenerated tobacco.
- Examples of the region used include the leaf (expanded tobacco), stem, rib (cut stem), root, and flower.
- the dimension of the shredded tobacco is not particularly limited.
- the shredded tobacco preferably has a sphere equivalent diameter of generally 1.5 mm or less and preferably 0.5 mm or less and generally 0.01 mm or more as measured by a projected sectional-area method (such as the method using Camsizer (Retsch Technology GmbH)).
- the tobacco filler contains shredded tobacco at 20% by mass or more, preferably 30% by mass or more and more preferably 40% by mass or more, and 80% by mass or less, preferably 70% by mass or less and more preferably 60% by mass or less.
- the content within the above range allows easier suppression of a reduction in the amount of evaporated smoke flavor components and more effective suppression of "smoke flavor inhibition".
- the liquid that generates aerosol contains propylene glycol.
- Further examples of the liquid that generates aerosol include polyhydric alcohols such as glycerol, triethylene glycol and tetraethylene glycol; aliphatic esters of carboxylic acids such as methyl stearate, dimethyl dodecanedioate and dimethyl tetradecanedioate.
- the liquid used may be a combination of two or more.
- the liquid that generates aerosol contains propylene glycol.
- Propylene glycol is used for food and medicinal products as a highly safe solution and can easily generate visible smoke because of the low boiling point and liability of vaporisation. Meanwhile, propylene glycol has high vapour pressure, and thus is liable to volatilise in the oral cavity. Because of this, propylene glycol may create an atmosphere in which components inhibiting smoke flavor contained in aerosol are liable to volatilise, thereby more easily causing an issue of "smoke flavor inhibition". Consequently, characteristics of the tobacco filler may be more efficiently exploited.
- the tobacco filler contains liquid that generates aerosol at 20% by mass or more, preferably 30% by mass or more and more preferably 40% by mass or more, and 80% by mass or less, preferably 70% by mass or less and more preferably 60% by mass or less.
- the content within the above range allows easier suppression of a reduction in the amount of evaporated smoke flavor components and more effective suppression of "smoke flavor inhibition".
- the tobacco filler is characterised in that the tobacco filler contains an acid that has a first acid dissociation constant of 4.0 to 6.0 inclusive and a boiling point of 366°C to 600°C inclusive (hereinafter also abbreviated as "acid").
- the acid has a first acid dissociation constant of preferably 4.5 or more and preferably 5.5 or less.
- the acid has a boiling point of preferably 400°C or higher and preferably 560°C or lower.
- the first acid dissociation constant and the boiling point within the above ranges allows more effective suppression of "smoke flavor inhibition".
- the acid is at least one selected from ascorbic acid, isoascorbic acid, heneicosanoic acid, lignoceric acid, octacosanoic acid, and nonadecanoic acid.
- ascorbic acid and isoascorbic acid are particularly preferred.
- the acid as described above allows easier suppression of a reduction in the amount of evaporated smoke flavor components and more effective suppression of "smoke flavor inhibition".
- the tobacco filler contains the acid at 0.25% by mass or more and preferably 1% by mass or more and 10% by mass or less.
- the content within the above range allows easier suppression of a reduction in the amount of evaporated smoke flavor components and more effective suppression of "smoke flavor inhibition".
- the tobacco filler contains shredded tobacco, and liquid that generates aerosol.
- components contained in shredded tobacco such as water elute in the liquid that generates aerosol, and thus it can be regarded that the tobacco filler also contains water.
- the tobacco filler contains water at generally 5% by mass or more, preferably 7.5% by mass or more and more preferably 10% by mass or more, and generally 30% by mass or less, preferably 25% by mass or less and more preferably 20% by mass or less of the whole tobacco filler.
- the content within the above range allows easier suppression of a reduction in the amount of evaporated smoke flavor components and more effective suppression of "smoke flavor inhibition".
- Shredded tobacco used was obtained by grinding tobacco in a household mixer followed by shaking on a sieve (AS200, manufactured by Retsch Technology GmbH) under the condition: amplitude-1.5 mm/"g" for 2 minutes, and had a mesh size of 0.5 mm or less.
- the prepared sample was placed so as to attach to a pod dedicated to a product with the product name "Ploom ® " marketed by Japan Tobacco Inc., and stored for 2 days or more under the conditions of 22°C and humidity of 60%. It was verified that the heating temperature (during stable operation) of shredded tobacco using Ploom was about 160°C to 170°C by preliminary measurement using a thermocouple.
- the prepared pod was attached to Ploom and the amount of evaporated smoke flavor components during initial 10 puffs was measured under specified smoking conditions (55 ml/2s, smoking interval: 30s) on a smoking machine (Borgwaldt, RM-26).
- the indicative component selected was nicotine, which can be easily measured as a smoke flavor component.
- Smoke was trapped with a Cambridge filter pad, the smoke trapped on the filter was extracted in a methanol solvent while shaking for 40 minutes and nicotine was assayed by GC-FID.
- Fig. 2 indicates a graph illustrating the relationship between the first acid dissociation constant of acids and the amount of evaporated smoke flavor components. From Fig. 2 , it resulted that acids having low first acid dissociation constant had low amounts of smoke flavor components, and for most of acids having an acid dissociation constant of 4.0 or more, the amounts of smoke flavor components were equivalent to the amount of smoke flavor components without addition of acid. From this result, it was found that by using an acid having a first acid dissociation constant of 4.0 or more, the amount of evaporated smoke flavor components does not decrease. As most of acids have a first acid dissociation constant or 6.0 or less by taking the pH of acids into account, the ideal range of the first acid dissociation constant is 4.0 to 6.0 inclusive.
- Fig. 3 indicates a graph illustrating the relationship between the boiling point of acids having a first acid dissociation constant of 4.0 to 6.0 inclusive and smoke flavor inhibition. It was found that at a boiling point of 366°C or higher, smoke flavor inhibition could be reduced with almost all acids, and thus the boiling point was important for reduction of smoke flavor inhibition.
- Fig. 4 indicates a graph illustrating the relationship between the boiling point of acids having a first acid dissociation constant of 4.0 to 6.0 inclusive and chemical odor. It was found that chemical odor decreased with acids having a boiling point of 366°C or higher. When the boiling point of acid is too high, the amount of acid released by heating decreases, and thus it is believed that the boiling point is preferably 600°C or lower.
- test was carried out in the same manner as in previous Examples except that the contents of acids, isoascorbic acid, lignoceric acid and nonadecanoic acid, were changed from 5% by mass in previous Examples to 3% by mass or 1% by mass. In the present evaluation, only an effect on smoke flavor inhibition was focused because the amounts of evaporated smoke flavor components are equivalent.
- Fig. 5 indicates a graph illustrating the relationship between the acid content and smoke flavor inhibition. From Fig. 5 , it may be observed that even when the content is reduced to 1% by mass, the effect of acid is high. This is merely because a highly effective acid can exhibit the effect at a low content. Because acids such as isoascorbic acid, lignoceric acid and nonadecanoic acid have high boiling points, the acids tend to be evaporated by heating, generate aerosol by condensation and remain in particles, and it is predicted that a high effect is obtained because the acids remain in aerosol even after dilution in the oral cavity during smoking. When the acid content is excessive, characteristics of acid may be noticeable, and thus a suitable content may be 10% by mass or less.
- the test was carried out in the same manner as in previous Examples and Comparative Examples except that the liquid that generates aerosol was varied.
- the solvents which were liquids that generate aerosol used were, in addition to propylene glycol, glycerol, diacetin and triethyl citrate (TEC), and the acid used was nonadecanoic acid.
- TEC triethyl citrate
- the results are shown in Fig. 6 .
- propylene glycol was used, the highest smoke flavor inhibition was obtained and the smoke flavor inhibition was low for other liquids. This indicates that the liquid that generates aerosol which is likely to exhibit the highest effect is propylene glycol, and the present technology is effective when a whole or a small amount of the liquid contained is propylene glycol.
- the tobacco filler may fill a non-combustion smoking article for smoking.
Landscapes
- Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Toxicology (AREA)
- Manufacture Of Tobacco Products (AREA)
Claims (3)
- Utilisation d'une charge de tabac pour un article à fumer sans combustion comprenant du tabac haché et un liquide qui génère un aérosol,dans laquelle la charge de tabac contient un acide qui présente une première constante de dissociation d'acide de 4,0 à 6,0 inclus et un point d'ébullition de 366 °C à 600 °C inclus,dans laquelle l'acide est au moins un sélectionné dans le groupe constitué par l'acide ascorbique, l'acide isoascorbique, l'acide hénéicosanoïque, l'acide lignocérique, l'acide octacosanoïque et l'acide nonadécanoïque,dans laquelle la charge de tabac contient le liquide qui génère un aérosol à raison de 20 % en masse ou plus et 80 % en masse ou moins, et le liquide qui génère un aérosol contient du propylène glycol (PG), etdans laquelle la charge de tabac contient le tabac haché à raison de 20 % en masse ou plus et 80 % en masse ou moins et l'acide à raison de 0,25 % en masse à 10 % en masse inclus de toute la charge de tabac.
- Utilisation de la charge de tabac selon la revendication 1, dans laquelle l'acide est au moins un sélectionné dans le groupe constitué par l'acide isoascorbique, l'acide hénéicosanoïque, l'acide lignocérique, l'acide octacosanoïque et l'acide nonadécanoïque.
- Article à fumer sans combustion qui est rempli avec la charge de tabac selon la revendication 1 ou 2.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/JP2016/065717 WO2017203686A1 (fr) | 2016-05-27 | 2016-05-27 | Remplissage de tabac pour article à fumer à chauffage de type sans combustion |
Publications (3)
Publication Number | Publication Date |
---|---|
EP3446577A1 EP3446577A1 (fr) | 2019-02-27 |
EP3446577A4 EP3446577A4 (fr) | 2019-12-25 |
EP3446577B1 true EP3446577B1 (fr) | 2022-08-24 |
Family
ID=60412187
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP16903167.1A Active EP3446577B1 (fr) | 2016-05-27 | 2016-05-27 | Remplissage de tabac pour article à fumer à chauffage de type sans combustion |
Country Status (8)
Country | Link |
---|---|
US (1) | US20190090531A1 (fr) |
EP (1) | EP3446577B1 (fr) |
JP (1) | JP6839181B2 (fr) |
KR (2) | KR20190005225A (fr) |
CN (1) | CN109152417B (fr) |
CA (1) | CA3025611C (fr) |
EA (1) | EA201892755A1 (fr) |
WO (1) | WO2017203686A1 (fr) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN113645861A (zh) * | 2019-03-29 | 2021-11-12 | 日本烟草产业株式会社 | 非燃烧型加热吸烟物品及其使用方法、以及非燃烧型加热吸烟系统 |
WO2021020348A1 (fr) | 2019-07-31 | 2021-02-04 | 日本たばこ産業株式会社 | Produit à base de tabac à chauffage sans combustion et produit à base de tabac chauffé |
EP4209136A4 (fr) * | 2020-09-03 | 2024-05-01 | Japan Tobacco Inc | Matériau de remplissage de tabac, inhalateur d'arôme de type chauffage sans combustion, et procédé de production d'un matériau de remplissage de tabac |
Family Cites Families (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ZA75351B (en) * | 1974-02-15 | 1976-01-28 | Hoffmann La Roche | Treatment of smoking material |
US4286606A (en) * | 1979-06-18 | 1981-09-01 | Philip Morris Incorporated | Tobacco flavorants |
GB2203022B (en) * | 1987-03-23 | 1991-11-20 | Imp Tobacco Co Ltd | Smoking material and process for making the same |
US4936920A (en) * | 1988-03-09 | 1990-06-26 | Philip Morris Incorporated | High void volume/enhanced firmness tobacco rod and method of processing tobacco |
GB9605554D0 (en) * | 1996-03-07 | 1996-05-15 | British American Tobacco Co | Suitable filler material for smoking articles |
US5713376A (en) | 1996-05-13 | 1998-02-03 | Berger; Carl | Non-addictive tobacco products |
US20060254606A1 (en) * | 2005-05-16 | 2006-11-16 | Fazlani Arif Abdul K | Novel smoking composition |
EP2100525A1 (fr) * | 2008-03-14 | 2009-09-16 | Philip Morris Products S.A. | Système de génération d'aérosol à chauffage électrique et procédé |
US8944072B2 (en) * | 2009-06-02 | 2015-02-03 | R.J. Reynolds Tobacco Company | Thermal treatment process for tobacco materials |
US8434496B2 (en) * | 2009-06-02 | 2013-05-07 | R. J. Reynolds Tobacco Company | Thermal treatment process for tobacco materials |
US10051884B2 (en) * | 2010-03-26 | 2018-08-21 | Philip Morris Usa Inc. | Controlled release mentholated tobacco beads |
US9192193B2 (en) * | 2011-05-19 | 2015-11-24 | R.J. Reynolds Tobacco Company | Molecularly imprinted polymers for treating tobacco material and filtering smoke from smoking articles |
CN102936535B (zh) * | 2012-11-23 | 2014-02-12 | 中国烟草总公司郑州烟草研究院 | 一种天然烟草增香剂的制备方法及其应用 |
JP6157169B2 (ja) | 2013-03-27 | 2017-07-05 | 株式会社Lixil | 連窓 |
CN114223928A (zh) | 2013-05-06 | 2022-03-25 | 尤尔实验室有限公司 | 用于气溶胶装置的烟碱盐调配物及其方法 |
WO2014190079A2 (fr) * | 2013-05-22 | 2014-11-27 | Njoy, Inc. | Compositions, dispositifs, et procédés pour administration d'aérosols de nicotine |
US9282771B2 (en) | 2013-07-09 | 2016-03-15 | Hector F. Figueroa | Ashtray system |
CN103478895B (zh) * | 2013-10-16 | 2015-09-30 | 山东临沂烟草有限公司 | 一种防止烟叶调制不当引起棕色化反应的方法 |
CN113754634A (zh) * | 2014-05-27 | 2021-12-07 | R.J.雷诺兹烟草公司 | 烟碱盐、共晶体和盐共晶体络合物 |
AU2016347736B2 (en) * | 2015-11-05 | 2020-08-27 | Philip Morris Products S.A. | Homogenized tobacco material with improved volatile transfer |
EP3714876A1 (fr) * | 2019-03-29 | 2020-09-30 | VitaSalts AG | Compositions d'évaporation destinées à l'inhalation |
-
2016
- 2016-05-27 CN CN201680085871.5A patent/CN109152417B/zh active Active
- 2016-05-27 EA EA201892755A patent/EA201892755A1/ru unknown
- 2016-05-27 EP EP16903167.1A patent/EP3446577B1/fr active Active
- 2016-05-27 CA CA3025611A patent/CA3025611C/fr active Active
- 2016-05-27 KR KR1020187036085A patent/KR20190005225A/ko not_active IP Right Cessation
- 2016-05-27 WO PCT/JP2016/065717 patent/WO2017203686A1/fr active Application Filing
- 2016-05-27 KR KR1020217041819A patent/KR102388942B1/ko active IP Right Grant
- 2016-05-27 JP JP2018518911A patent/JP6839181B2/ja active Active
-
2018
- 2018-11-26 US US16/200,239 patent/US20190090531A1/en active Pending
Also Published As
Publication number | Publication date |
---|---|
CA3025611C (fr) | 2020-07-28 |
EP3446577A4 (fr) | 2019-12-25 |
CN109152417A (zh) | 2019-01-04 |
KR102388942B1 (ko) | 2022-04-20 |
CN109152417B (zh) | 2022-01-11 |
JPWO2017203686A1 (ja) | 2019-03-14 |
WO2017203686A1 (fr) | 2017-11-30 |
KR20210158861A (ko) | 2021-12-31 |
CA3025611A1 (fr) | 2017-11-30 |
EA201892755A1 (ru) | 2019-05-31 |
JP6839181B2 (ja) | 2021-03-03 |
KR20190005225A (ko) | 2019-01-15 |
US20190090531A1 (en) | 2019-03-28 |
EP3446577A1 (fr) | 2019-02-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP3473117B1 (fr) | Charge de tabac pour article à fumer à chaleur de type sans combustion | |
US20190090531A1 (en) | Tobacco filling for non-combustion-type heating smoking article | |
JP2022106990A (ja) | 製品 | |
US20220408784A1 (en) | Tobacco filling for non-combustion-type heating smoking article | |
EP4027816A1 (fr) | Formulation aérosolisable | |
JP7087136B2 (ja) | 非燃焼型加熱喫煙物品用のたばこ充填物 | |
TWI650082B (zh) | 非燃燒型加熱吸煙物品用的煙草填充物 | |
TWI629006B (zh) | 非燃燒型加熱吸煙物品用的煙草填充物 | |
TWI627910B (zh) | 非燃燒型加熱吸煙物品 | |
WO2023008063A1 (fr) | Liquide pour cigarettes électroniques, procédé de fabrication de liquide pour cigarettes électroniques, cartouche pour cigarette électronique et cigarette électronique | |
EA040319B1 (ru) | Табачный наполнитель для нагревательного курительного изделия негорючего типа |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE |
|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE |
|
17P | Request for examination filed |
Effective date: 20181120 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR |
|
AX | Request for extension of the european patent |
Extension state: BA ME |
|
DAV | Request for validation of the european patent (deleted) | ||
DAX | Request for extension of the european patent (deleted) | ||
A4 | Supplementary search report drawn up and despatched |
Effective date: 20191121 |
|
RIC1 | Information provided on ipc code assigned before grant |
Ipc: A24B 15/12 20060101ALI20191115BHEP Ipc: A24F 47/00 20060101AFI20191115BHEP Ipc: A24B 15/32 20060101ALI20191115BHEP Ipc: A24B 15/30 20060101ALI20191115BHEP Ipc: A24B 15/28 20060101ALI20191115BHEP Ipc: A24B 15/14 20060101ALI20191115BHEP |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: EXAMINATION IS IN PROGRESS |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: EXAMINATION IS IN PROGRESS |
|
17Q | First examination report despatched |
Effective date: 20201016 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: EXAMINATION IS IN PROGRESS |
|
GRAP | Despatch of communication of intention to grant a patent |
Free format text: ORIGINAL CODE: EPIDOSNIGR1 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: GRANT OF PATENT IS INTENDED |
|
INTG | Intention to grant announced |
Effective date: 20220315 |
|
RAP3 | Party data changed (applicant data changed or rights of an application transferred) |
Owner name: JAPAN TOBACCO INC. |
|
GRAS | Grant fee paid |
Free format text: ORIGINAL CODE: EPIDOSNIGR3 |
|
GRAA | (expected) grant |
Free format text: ORIGINAL CODE: 0009210 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE PATENT HAS BEEN GRANTED |
|
AK | Designated contracting states |
Kind code of ref document: B1 Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR |
|
REG | Reference to a national code |
Ref country code: CH Ref legal event code: EP |
|
REG | Reference to a national code |
Ref country code: DE Ref legal event code: R096 Ref document number: 602016074566 Country of ref document: DE |
|
REG | Reference to a national code |
Ref country code: IE Ref legal event code: FG4D |
|
REG | Reference to a national code |
Ref country code: AT Ref legal event code: REF Ref document number: 1513062 Country of ref document: AT Kind code of ref document: T Effective date: 20220915 |
|
REG | Reference to a national code |
Ref country code: LT Ref legal event code: MG9D |
|
REG | Reference to a national code |
Ref country code: NL Ref legal event code: MP Effective date: 20220824 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: SE Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20220824 Ref country code: RS Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20220824 Ref country code: PT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20221226 Ref country code: NO Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20221124 Ref country code: NL Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20220824 Ref country code: LV Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20220824 Ref country code: LT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20220824 Ref country code: FI Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20220824 |
|
REG | Reference to a national code |
Ref country code: AT Ref legal event code: MK05 Ref document number: 1513062 Country of ref document: AT Kind code of ref document: T Effective date: 20220824 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: PL Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20220824 Ref country code: IS Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20221224 Ref country code: HR Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20220824 Ref country code: GR Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20221125 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: SM Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20220824 Ref country code: RO Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20220824 Ref country code: ES Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20220824 Ref country code: DK Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20220824 Ref country code: CZ Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20220824 Ref country code: AT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20220824 |
|
REG | Reference to a national code |
Ref country code: DE Ref legal event code: R097 Ref document number: 602016074566 Country of ref document: DE |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: SK Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20220824 Ref country code: EE Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20220824 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: AL Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20220824 |
|
PLBE | No opposition filed within time limit |
Free format text: ORIGINAL CODE: 0009261 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT |
|
P01 | Opt-out of the competence of the unified patent court (upc) registered |
Effective date: 20230530 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: IT Payment date: 20230526 Year of fee payment: 8 Ref country code: FR Payment date: 20230526 Year of fee payment: 8 Ref country code: DE Payment date: 20230519 Year of fee payment: 8 |
|
26N | No opposition filed |
Effective date: 20230525 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: SI Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20220824 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: GB Payment date: 20230524 Year of fee payment: 8 |
|
REG | Reference to a national code |
Ref country code: CH Ref legal event code: PL |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: MC Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20220824 |
|
REG | Reference to a national code |
Ref country code: BE Ref legal event code: MM Effective date: 20230531 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: MC Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20220824 Ref country code: LU Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20230527 Ref country code: LI Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20230531 Ref country code: CH Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20230531 |
|
REG | Reference to a national code |
Ref country code: IE Ref legal event code: MM4A |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: IE Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20230527 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: IE Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20230527 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: BE Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20230531 |